CA23905-8 - 0x000000000000350B

Study Number: CA23905
Group Number: 8
Study Requirement: COPD
Stipend: up to £ 1,402

Study Criteria:

  • Age: 40 - 75
  • BMI: 0 - 0
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat COPD
  • Route of Administration: Inhalation; Oral
  • Blood Draws: 5

Study Schedule:

  • Schedule Type: Return Only
  • Study Length: 5 Returns

Screening Dates:

Event Day Event Date Site
Thursday May 24 2018 Belfast
Thursday May 24 2018 Belfast
Wednesday May 30 2018 Belfast

Doctor Exam Dates:

Event Day Event Date Site
Thursday May 24 2018 Belfast

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Thursday Jun 7 2018 6:30AM Thursday Jun 7 2018 3:00PM 1 Belfast
Return Thursday Jul 5 2018 11:30AM Thursday Jul 5 2018 3:00PM 1 Belfast
Return Thursday Aug 2 2018 11:30AM Thursday Aug 2 2018 3:00PM 1 Belfast
Return Thursday Aug 30 2018 11:30AM Thursday Aug 30 2018 2:45PM 1 Belfast
Return Thursday Sep 13 2018 11:30AM Thursday Sep 13 2018 2:45PM 1 Belfast